My ePortfolio Register   

Editorial Board

Michelle Lockley

Queen Mary, University of London, UK

Dr Lockley is a CRUK Clinician Scientist and Medical Oncology Consultant specialising in gynaecological cancer.


She studied medicine at University College London and undertook her postgraduate training in Medical Oncology at St Bartholomew's Hospital, London and Addenbrooke's Hospital Cambridge. Funded initially by CR-UK, and then by a MRC Clinical Research Training Fellowship, she completed her PhD in viral gene therapy at Queen Mary University of London, investigating the anti-tumour efficacy of adenoviral gene therapy in ovarian cancer. She was subsequently appointed Clinical Lecturer at the University of Cambridge where she studied the activity of a novel heparin sulphate mimetic in preclinical models of pancreatic cancer. She has since returned to the Barts Cancer Institute as a Senior Lecturer and Honorary Medical Oncology Consultant. She obtained a CRUK Clinician Scientist Fellowship in 2011 to pursue her interest in viral gene therapy and ovarian cancer. Her particular research focus is the virus-induced inflammatory response and how this can be manipulated for therapeutic benefit.


Dr Lockley utilises primary ovarian cancer cells in her research and has recently set up the Barts Gynae Tissue Bank for which she is PI.
 



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence